Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease

被引:526
作者
Ong, Janus P. [1 ,2 ]
Pitts, Angela [3 ]
Younossi, Zobair M. [1 ,2 ]
机构
[1] Inova Fairfax Hosp, Ctr Liver Dis, Annandale, VA 22003 USA
[2] Inova Hlth Syst, Outcomes Res Program, Falls Church, VA USA
[3] RTI Int, Res Triangle Pk, NC USA
关键词
NAFLD; NASH; liver-related mortality; USA;
D O I
10.1016/j.jhep.2008.06.018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims:The natural history of non-alcoholic fatty liver disease (NAFLD) remains to be defined. We conducted a study to determine the overall and liver-related mortality of NAFLD in the general US population. Methods: In this study, the Third National Health and Nutrition Examination Survey (NHANES III) and NHANES III-Linked Mortality File were used. Adjusted hazard ratios (HR) for overall and liver-related mortality were calculated for NAFLD using persons without liver disease as reference. Causes of death were determined. Results: After a median follow-up of 8.7 years, 80 persons with NAFLD and 1453 without liver disease died. Older age, male gender, non-Hispanic white race, lower educational level, lower income, higher BMI, presence of hypertension, diabetes mellitus, or metabolic syndrome were significantly (p < 0.05) associated with overall mortality. Persons with NAFLD had higher overall mortality [HR 1.038 (95% CI 1.036-1.041), P < 0.0001] and liver-related mortality [HR 9.32 (95% CI 9.21-9.43), P < 0.0001]. Liver disease was the third leading cause of death among persons with NAFLD after cardiovascular disease and malignancy. Conclusions: NAFLD is associated with higher overall and liver-related mortality in the general US population. Liver disease is a significant cause of death among persons with NAFLD. (C) 2008 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:608 / 612
页数:5
相关论文
共 19 条
[1]   The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].
Adams, LA ;
Lymp, JF ;
St Sauver, J ;
Sanderson, SO ;
Lindor, KD ;
Feldstein, A ;
Angulo, P .
GASTROENTEROLOGY, 2005, 129 (01) :113-121
[2]  
[Anonymous], ANAL REPORTING GUIDE
[3]   Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[4]  
Bugianesi E, 2007, Clin Liver Dis, V11, P191, DOI 10.1016/j.cld.2007.02.006
[5]  
Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Long term prognosis of fatty liver: risk of chronic liver disease and death [J].
Dam-Larsen, S ;
Franzmann, M ;
Andersen, IB ;
Christoffersen, P ;
Jensen, LB ;
Sorensen, TIA ;
Becker, U ;
Bendtsen, F .
GUT, 2004, 53 (05) :750-755
[8]  
Dunn W, 2008, GASTROENTEROLOGY, V134, pA781
[9]   Long-term follow-up of patients with NAFLD and elevated liver enzymes [J].
Ekstedt, Mattias ;
Franzen, Lennart E. ;
Mathiesen, Ulrik L. ;
Thorelius, Lars ;
Holmqvist, Marika ;
Bodemar, Goran ;
Kechagias, Stergios .
HEPATOLOGY, 2006, 44 (04) :865-873
[10]   Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C [J].
Hui, JM ;
Kench, JG ;
Chitturi, S ;
Sud, A ;
Farrell, GC ;
Byth, K ;
Hall, P ;
Khan, M ;
George, J .
HEPATOLOGY, 2003, 38 (02) :420-427